Molecular cloning of genes differentially regulated by TNF-α in bovine aortic endothelial cells, fibroblasts and smooth muscle cells

Cardiovascular Research

Volumn 38, Issue 3, 1998, Pages 802-813

  Lin, Jie ^a,c   Liliensiek, Birgit ^a   Kanitz, Michael ^a   Schimanski, Ulrike ^a   Böhrer, Hubert ^a   Waldherr, Rüdiger ^b   Martin, Eike ^a   Kauffmann, Günter ^a   Ziegler, Reinhard ^a   Nawroth, Peter P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Department of Pathology ^*  (Germany)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Atherosclerosis; Cellular; Cytokines; Endothelial function; Experimental; Gene expression; Molecular biology; Smooth muscle; Vascular

Indexed keywords

COMPLEMENTARY DNA; FIBRONECTIN; GROWTH FACTOR; RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; AORTA; AORTA ANEURYSM; ARTICLE; ATHEROSCLEROSIS; CATTLE; CONTROLLED STUDY; DNA SEQUENCE; ENDOTHELIUM CELL; FIBROBLAST; GENE REPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MOLECULAR CLONING; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

ANIMALS; AORTA; BLOTTING, NORTHERN; CATTLE; CELLS, CULTURED; CLONING, MOLECULAR; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FIBROBLASTS; GENE EXPRESSION REGULATION; IN SITU HYBRIDIZATION; MUSCLE, SMOOTH, VASCULAR; SEQUENCE ANALYSIS, DNA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032103816     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00055-8     Document Type: Article

References (42)

1. [1] Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809.
2. [2] Busse R, Fleming I. Endothelial dysfunction in atherosclerosis. J Vasc Res 1996;33:181-194.
3. [3] Folkman J, Shing J. Angiogenesis. J Biol Chem 1992;267:10931-10934.
4. [4] Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? - G.H.A. Clowes memorial award lecture. Cancer Res 1986;46:467-473.
5. [5] Valassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A. Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science 1988;240:1546-1548.
6. [6] Sherry B, Cerami A. Cachetin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses. J Cell Biol 1988;107:1269-1277.
7. [7] Nawroth PP, Bank I, Handley D, Cassimeris J, Chess L, Stern DM. Tumor necrosis factor/cachetin interacts with endothelial cell receptors to induce release of interleukin 1. J Exp Med 1986;163:1363-1375.
8. [8] Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MA Jr. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 1987;84:9238-9242.
9. [9] Pober JS, Gimbrone MA Jr, Lapierre LA, et al. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 1986;137:1893-1896.
10. [10] Nawroth PP, Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986;163:740-745.
11. [11] Yamamoto K, Loskutoff DJ. Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. J Clin Invest 1996;97:2240-2451.
12. [12] Dixit VM, Green S, Sarma V, et al. Tumor necrosis factor-α induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. J Biol Chem 1990;265:2973-2978.
13. [13] Opipari AW, Boguski MS, Dixit VM. The A20 cDNA induced by tumor necrosis factor a encodes a novel type of zinc finger protein. J Biol Chem 1990;265:14705-14708.
14. [14] Sarma V, Wolf FW, Marks RM, Shows TB, Dixit VM. Cloning of a novel tumor necrosis factor-α-inducible primary response gene that is differentially expressed in development and capillary tube-like formation in vitro. J Immunol 1992;148:3302-3312.
15. [15] Wolf FW, Marks RW, Sarma V, et al. Characterization of a novel tumor necrosis factor-α-induced endothelial primary response gene. J Biol Chem 1992;267:1317-1326.
16. [16] Lentz SR, Tsiang M, Sadler JE. Regulation of thrombomodulin by tumor necrosis factor-α: comparison of transcriptional and posttranscriptional mechanisms. Blood 1991;77:542-550.
17. [17] Nishida K, Harrison DG, Navas JP, et al. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Inv 1992;90:2092-2096.
18. [18] Marczin N, Antonov A, Papapetropoulos A, et al. Monocyte-induced downregulation of nitric oxide synthase in cultured aortic endothelial cells. Arterioscler Thromb Vasc Biol 1996;16:1095-1103.
19. [19] Patterson C, Perrella MA, Endege WO, Yoshizumi M, Lee ME, Haber E. Downregulation of vascular endothelial growth factor receptors by tumor necrosis factor-α in cultured human vascular endothelial cells. J Clin Invest 1996;98:490-496.
20. [20] Schwartz SM. Selection and characterization of bovine aortic endothelial cells. In Vitro 1978;14:966-980.
21. [21] Stepp MA, Kindy MS, Franzblau C, Sonenshein GE. Complex regulation of collagen gene expression in cultured bovine aortic smooth muscle cells. J Biol Chem 1986;261:6542-6547.
22. [22] Sambrook J, Fritsch EF, Maniatis T, Molecular cloning: a laboratory manual, 2nd edn. New York: Cold Spring Harbor, Cold Spring Harbor Laboratory, 1989.
23. α.. Proc Natl Acad Sci USA 1984;81:2194-2198.
24. [24] Rhyner TA, Biguet NF, Berrard S, Borbély AA, Mallet J. An efficient approach for the selective isolation of specific transcripts from complex brain mRNA populations. J Neurosci Res 1986;16:167-181.
25. [25] Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977;74:5463-5467.
26. [26] Kafatos FC, Jones CW, Efstratiadis A. Determination of nucleic acid sequence homologies and relative concentrations by a dot hybridization procedure. Nuc Acids Res 1979;7:1541-1552.
27. [27] Greenberg MB, Ziff EB. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 1984;311:433-438.
28. [28] Almendral JM, Sommer D, Macdonald-Bravo H, Burckhardt J, Perera J, Bravo R. Complexity of the early genetic response to growth factors in mouse fibroblasts. Mol Cell Biol 1988;8:2140-2148.
29. [29] Zhang Y, Deng J, Luther T, et al. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest 1994;94:1320-1327.
30. [30] Zhang Y-M, Bachmann S, Hemmer C, et al. Vascular origin of Kaposi's sarcoma: expression of leukocyte adhesion molecule-1, thrombomodulin, and tissue factor. Am J Pathol 1994;144:51-59.
31. [31] Ritthaler U, Deng Y, Zhang Y, et al. Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease. Am J Pathol 1995;146:688-694.
32. [32] Zhang Y, Deng Y, Wendt T, et al. Intravenous somatic gene transfer with antisense tissue factor restores blood flow by reducing tumor necrosis factor-induced tissue factor expression and fibrin deposition in mouse meth-A sarcomas. J Clin Invest 1996;97:2213-2224.
33. [33] Schneider C, King RM, Philipson L. Genes specifically expressed at growth arrest of mammalian cells. Cell 1988;54:787-793.
34. [34] Partridge CA, Horvath CJ, Del Vecchio PJ, Phillips PG, Malik AB. Influence of extracellular matrix necrosis factor-induced increase in endothelial permeability. Am J Physiol 1992;263:L627-L633.
35. [35] Stolpen AH, Guinan EC, Fiers W, Pober JS. Recombinant tumor necrosis factor and immune interferone act singly and in combination to reorganize human vascular endothelial cell monolayers. Am J Pathol 1986;123:16-24.
36. [36] Wheatley EM, Vincent PA, McKeown-Longo PJ, Saba TM. Effect of fibronectin on permeability of normal and TNF-treated lung endothelial cell monolayers. Am J Physiol 1993;264:R90-R96.
37. [37] Yao J, Bone RC, Sawhney RS. Differential effects of tumor necrosis factor-alpha on the expression of fibronectin and collagen genes in cultured bovine endothelial cells. Cell Mol Biol Res 1995;41:17-28.
38. [38] Hines KL, Kulkarni AB, McCarthy JB, et al. Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor β1 knockout mice. Proc Natl Acad Sci USA 1994;91:5187-5191.
39. [39] Bradham DM, Igarashi A, Potter RL, Grotendorst GR. Connective tissue growth factor: a cystein-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 1991;114:1285-1294.
40. [40] Bork P. The molecular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS L 1993;327:125-130.
41. [41] Oemar BS, Werner A, Garnier JM, et al. Human connective tissue factor is expressed in advanced atherosclerotic lesions. Circulation 1997;95:831-839.
42. [42] Soma Y, Grotendorst GR. TGF-β stimulates primary human skin fibroblasts DNA synthesis via an autocrine production of PDGF-related peptides. J Cell Physiol 1989;140:246-253.